master's thesis
CHARACTERISTICS OF INTERFERON BETA 1a AND 1b THERAPY IN MULTIPLE SCLEROSIS PATIENTS

Tina Gogić (2017)
University of Split
School of Medicine
Neurology
Cite this document

Gogić, T. (2017). ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM (Master's thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, Tina. "ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM." Master's thesis, University of Split, School of Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, Tina. "ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM." Master's thesis, University of Split, School of Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, T. (2017). 'ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM', Master's thesis, University of Split, School of Medicine, accessed 19 September 2019, https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić T. ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM [Master's thesis]. Split: University of Split, School of Medicine; 2017 [cited 2019 September 19] Available at: https://urn.nsk.hr/urn:nbn:hr:171:005204

T. Gogić, "ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM", Master's thesis, University of Split, School of Medicine, Split, 2017. Available at: https://urn.nsk.hr/urn:nbn:hr:171:005204